News & Events - Zestagen Healthcare

News & Events

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis
Source: Pharmafile Published on 2024-10-21 By Natalia Elliot
Eli Lilly appoints new chief AI officer
Source: Pharmafile Published on 2024-10-17 By Natalia Elliot
FlyPharma Europe, Vienna – 23-24 October 2024 conference
Source: Pharmafile Published on 2024-10-14 By Natalia Elliot
Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study
Source: Pharmafile Published on 2024-10-03 By Natalia Elliot
Strategic alliance announced between Recipharm and Exela
Source: Pharmafile Published on 2024-10-01 By Natalia Elliot
Santhera Pharmaceuticals announces LIONHEART study results for corticosteroid vamorolone
Source: Pharmafile Published on 2024-10-01 By Natalia Elliot
Prilenia appoints new management staff to advance company’s development and commercialisation plans
Source: Pharmafile Published on 2024-09-30 By Natalia Elliot
Vertex Highlights First Oral Presentation of Phase 3 Clinical Dataof the Vanzacaftor Triple Combination and New Data on Long-Term Impact of TRIKAFTA at the North American CysticFibrosis Conference
Source: Pharmafile Published on 2024-09-30 By Natalia Elliot
Eli Lilly announces two senior hires in Public Affairs and Communications team
Source: Pharmafile Published on 2024-09-27 By Natalia Elliot
Laurence Reid and Brad Crutchfield appointed to Broken Strings’ board of directors
Source: Pharmafile Published on 2024-09-25 By Natalia Elliot
Third application for Orion’s prostate cancer drug submitted by partner Bayer
Source: Pharmafile Published on 2024-09-23 By Natalia Elliot
Expanded possibilities for laboratory digitalization and connectivity: labforward merges with LabTwin
Source: Pharmafile Published on 2024-09-19 By Natalia Elliot
Steriline’s founder “passes torch” to children with CEO and CSO appointments
Source: Pharmafile Published on 2024-09-19 By Natalia Elliot
Butterfly Network Expands its Next-Generation Butterfly iQ3™ to Europe
Source: Pharmafile Published on 2024-09-11 By Natalia Elliot
Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders
Source: Pharmafile Published on 2024-09-09 By Natalia Elliot
Amferia closes €1,2 million investment to combat resistant bacterial infections
Source: Pharmafile Published on 2024-09-03 By Natalia Elliot
The National Institute for Health and Care Excellence announce technology appraisal guidance recommending risankizumab for adult patients with moderate to severe ulcerative colitis
Source: Pharmafile Published on 2024-08-29 By Natalia Elliot
Leadership Appointments at RQM+
Source: Pharmafile Published on 2024-08-28 By Natalia Elliot
European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated non-small cell lung cancer in adult patients
Source: Pharmafile Published on 2024-08-27 By Natalia Elliot
New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain
Source: Pharmafile Published on 2024-08-16 By Natalia Elliot

Therapeutic Class

Anti-Infectives

Antivirals

Pain Management

Cardiovascular Agents

Anti-Diabetics

CNS

Antihistamines

Respiratory Agents

Gastrointestinals

Urology

Supplements

Others

Our commitment will
make you win

We Zestagen Healthcare are dedicated to contributing towards the growth and prosperity of the community through innovation in the healthcare sector. Our unmatched and undiluted focus is on maximizing the value of stakeholders and customers by delivering a comprehensive array of products and services as per global standards.

Our manufacturing facilities are committed to implementing Good manufacturing practices (GMP) and Good laboratory practices (GLP). Thereby, the products are manufactured with highquality standards which are maintained at each and every stage of the manufacturing process. The facilities are equipped with advanced automation systems and automatic data recording monitors for process control like air distribution, temperature, humidity, auto cleaning process, etc.

Our business model

Our business model that outlines how a company creates, delivers, and captures value. It serves as a blueprint for how a business operates, generates revenue, and sustains itself over time.

The importance of a well-defined business model lies in its ability to provide numerous strategic and operational benefits.

Interested? Let's Talk

Contact us directly to receive full information on the product, the formulation, the science behind it, stability data, and more.

Certifications

Global Presence